Clinical Trial Update: Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections [Phase 2, Phase 3]

View source ↗

Summary

This update summarizes safety and efficacy findings for guaifenesin (Mucinex, IR formulation) in acute upper respiratory tract infections from Phase 2 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• MUCINEX (guaifenesin)

Snippet

Sponsor: Reckitt Benckiser LLC | Conditions: Acute Upper Respiratory Tract Infection | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-09-12